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nary endothelial dysfunction assessed by cold pressor testmg is predictive of long-term 
cardiovascular event in type 2 diabetic patients with angiographically normal coronary 
arteries and without other coronary risk factor. 
1131-140 Hemodynamic Effects of Aqueous Nitric Oxide 
Solutions Applied Directly Into Human Coronary 
Circulation 
Make Kelm Julius Rath, P&a Kleinbongard, Tienush Rassaf, Michael Preik, Bodo E. -3 
Strauer, Universitatsklinikum Diisseldorf, Diisseldorf, Germany 
Background: Nitric oxide (NO) has been shown to dilate vessels and to inhibit platelet 
function, both effects highly desirable during percutaneous intervention (PCI) in patients 
with coronary artery disease (CAD). Whether or not NO applied directly into human coro- 
nary circulation exerts biological effects is unknown so far. Therefore, the aims of our 
study were: (i) to develop a method for reproducible production of sterile solutions con- 
taining authentic NO, (ii) to find a save mode of intracoronary (ic.) application, and (iii) 
and to characterize potential dilatory effects in conduit and resistance coronary arteries. 
Methods: Changes in coronary blood flow (CBF) were quantified by quantitative coro- 
nary angiography (QCA) and intracoronary Doppler guide wares (ICD) in 13 patients with- 
out flow limiting CAD after application of either saline controls, aqueous NO solutions 
(NO.1 -6 wmol), adenosin (ADO, 2.4mg/min) or tsosorbiddinitrate (ISDN, 0.3 mg) in ran- 
dom order. 
Results: NO dilated epicardial arteries I” a dose-dependent manner up to lo+_1 %, equiv- 
alent to that seen upon ISDN. In parallel average peak velocity (APV) increased from 21 
to 51+4 cm/s. Thus NO dilated coronary microvasculature to almost the same degree as 
seen after infusion of adenosine, whereas ISDN increased APV only slightly. Conse- 
quently. coronary blood flow increased according to the following rank order: NO and 
ADO > ISDN, whereas saline controls ware without effect. NO induced increases in CBF 
lasted much longer than expected from Its biochemical life span in human blood. Heart 
rate or blood pressure remained unaffected. 
Conclusions:Aqueous NO solutions can be applied directly into human coronary circu- 
lation and dilate uniformly epicardial and resistance arteries increasing coronary blood 
flow severalfold. These findings offers the avenue to selectively increase local NO stores 
within the coronary circulation without exerting systemic side effect?. 
1131-141 Coronary Endothelial Function: The Impact of Aging in 
a Matched Study Group With Normal Coronary Arteries 
Jan L. Houahton, Patricia Kuhner, Mikhail Torosoff, Michael Prisant, Albany Medical 
College, Albany, NY 
Background: Coronary endothelial vasodilator function is attenuated with aging. It is 
unknown whether this finding is simply related to greater prevalence of risk factors and/or 
subclinical atherosclerosts among the elderly or alternatively to a drrect or indirect effect 
of aging. Methods: Using graded coronary infustons of acetylcholine (ACh), endoihelial 
function was tested in 25 patients between the ages of 20 and 45 years (defined as 
young) and in 25 matched patients aged 60 or older (defined as old). All patients had 
angiographic normal coronary arteries and were matched for gender, race, body mass 
Index (BMI), indexed left ventricular mass (LVMH), low density lipoprotein cholesterol 
(LDL-C), and mean arterial pressure. Results: The study included 14 women and 11 men 
in each of the young and old groups. Age was 36.6 +/- 1.2 years in the young group and 
64.6 +I- 0.7 in the old. Both groups were moderately overweight but not obese. Both 
were normotensive without left ventricular hypertrophy and LDL-C was less than 135 mgl 
dl in both. Dose response curves relating % increase in coronary blood flow (CBF) to 
ACh dose ware significantly attenuated among the elderly subjects (p=O.O13 by ANOVA) 
despite similar BMI, LVMH, LDL-C, and blood pressure. Peak increase in CBF after ACh 
was 228 +/- 18% among the young and 162 +/- 23% among the old (p=O.O3). After intra- 
coronary adenosine, peak increase in CBF was also depressed among the old (211 +I- 
11% vs 173 +/- 16%. p=O.O6). Among the young cohort, 16 of 25 (64%) had greater than 
200% increase in CBF above baseline after ACh, a finding present in only 6 of 25 (24%) 
in the old cohorl, p=O.Ol. Conclusion: In a group of patients with normal coronary arteries 
matched for body habitus, LVMH, LDL-C, and MAP, aging was associated with depres- 
sion in endothellal and vasomotor function as indicated by CBF responses to ACh and 
adenosine. Mechanisms consistent with these results include a direct effect of aging and/ 
or the composrte effect of multiple low level atherogenic processes over time. 
1131-142 The Relationship of Oxidative Stress to Vascular Health 
in Humans 
Salman Ashfaq Jerome L. Abramson, Steven D. Rhodes, Sean C. Beinari, Claudine 
Jurkovitz, Jovonne K. Williams, Viola Vaccarino, Arshed A. Quyyumi. William S. 
Weintraub, David G. Harrison, Emory University, Atlanta, GA 
Background: Experimental animal studies have shown an association between oxida- 
tive stress and measures of early atherosclerosis. There is, however, considerably less 
evidence for this association in humans. A measure of lipid peroxidation in the blood, 
known as Free Oygen Radical Monitor or FORM, has been shown to be a marker of OXI- 
dative stress in humans. We hypothesized that this marker would correlate with other 
measures of vascular health. 
Methods: 40 subjects with no overt atherosclerotic disease were enrolled. As measures 
of vascular health. ultrasound evaluation of common carotid artery intima media thick- 
ness (CIMT), and brachial artery flow mediated dilation (FMD) were performed. FMD is a 
measure of vascular endothelial function. Plasma levels of high sensttivity C-reactive pro- 
tein (HsCRP) were also assessed. We correlated these markers with the FORM assay. 
Results: There was an inverse correlation between FMD and FORM (I = -0.41, p- 0 01). 
FORM also had a significant correlation with CIMT (r=0.42, p-0.01). There was also a 
strong correlation between FORM and HsCRP (r=0.72, p-~0.001). The subjects were 
also stratifred based on their FORM results into those with 2 391 and those < 391 Carr 
Units. The results of the various markers of vascular health are shown below. 
FORM < 391 (Carr Units) FORM> 391 (Carr Units) P-value 
HsCRP (mg/L) 1.45 (+I-2.5) 6.96 (+/-8.3) 0.01 
CIMT (mm) 0.57 (+/-0.10) 0.66 (+/-0.14) ,086 
FMD (%) 7.07 (+/-2.5) 4.93 (+/-2.3) .013 
Conclusion: The marker of oxidatlve stress, FORM, predicts Individuals with elevated 
HsCRP, abnormal endothelial function, and early atherosclerosis. This suggests that it 
can be used a marker of overall vascular health in humans. 
1131-143 Comparison Between the Flow Velocity: Pressure 
Gradient Relation and the Coronary and Fractional Flow 
Reserve in the Assessment of Coronary Stenoses 
Keen M. Maraues. Hugo J. Spruijt, NICO Westerhof, Cees A. Vrsser, Frans C. Visser, VU 
University Medical Center, Amsterdam, The Netherlands, ICaR-VU, Amsterdam, The 
Netherlands 
Background. Recently, we assessed the feasiblllty and reproducibrlity of the flow veloc- 
ity - pressure gradient (v-dp) relation. This index involves simultaneous measurement of 
both the diastolic flow velocity(v) and pressure gradient (dp), giving a comprehensive 
description of the hemodynamics of a coronary stenosis. The aim of the study was to 
compare the value of the v-dp relation with the coronary flow velocity reserve (CFVR) 
and fractional flow reserve (FFR) in the assessment of the severity of a coronary steno- 
sis. 
Methods. In all patients a MIBI SPECT or dobutam!ne stress echocardiogram was per- 
formed to detect and locate ischemia. A Doppler and a pressure wire were positioned 
distal to 90 intermediate coronary stenoses. After administration of adenosine the Instan- 
taneous flow velocity, the proximal and distal coronary pressure were digitally recorded. 
The v-dp relation was computed as described earlier. A ROC curve was used to deter- 
mine the best cut-off pomt of the v-dp relation. For the CFVR and FFR the cut-off points 
2.0 and 0.75 were used. Sensitivity, speciflciiy, and degree of agreement (kappa) were 
compared for the three indexes. 
Results The v-dp relation had a higher sensitivity but a lower specificity compared to the 
FFR. Overall, the v-dp relation was significantly (*p<O.OOOl) better than the FFR or 
CFVR to asse?s the significance of coronary stenoses. 
Conclusion. The v-dp relation more accurately predicts the significance of coronary 
stenoses compared to the CFVR or the FFR. 
sensitivity 
specificity 
kappa 
CFRV 
63% 
80% 
0.40*0.07 
FFR 
65% 
97% 
0.68*0.07 
v-dp relation 
100% 
86% 
0.76*0.05 
1131-144 Experimental Hyperhomocysteinemia Rapidly Impairs 
Coronary Flow Velocity Reserve in Healthy Adults 
Hiroyuki Takatsu, Hiromi Tasaki, Yoshitaka Nagai, Hiroshi Suzuka, Kazuhlto Yamashita, 
Yasuhide Nakashlma, University Occupied Environmental Health, Kitakyushu, Japan 
Background: Moderate elevations in plasma homocysteine concentrations are associ- 
ated with ischemlc heart disease. We tested the hypothesis that experimental hyperho- 
mocysteinemia would impair coronary endothelial function by increasing superoxide 
production. Methods: We studled 11 healthy volunteers 23.4 * 0.9 years of age on aver- 
age. Coronary flow velocity was measured by transthoracic-Doppler echocardiography 
before and 4 hours after placebo, oral methionme (L-methionine O.lgikg), or oral 
methionine plus vitamin C (29). on separate days in random order. 
Results: In methionina group, plasma homocysteine level rncreased from 12.9+ 
7.0nmoWml to 32.lr 9.4nmollml (p<O.OOOl), while the averaged diastolic peak velocity 
under hyperemic conditions (ADPV-hyp) and coronary flow velocity reserve (CFVR) 
decreased significantly (from 87.2+ 11.4cmlsec and 4.1* 0.7 to 75.52 11.2cmlsec and 
3.5 * 0.5, p=O.O248 and 0.0264, respect&y). With simultaneously administration of vita- 
rn~n C, however, ADPV-hyp and CFVR did not decreased (from 84.4 * 20.2cmisec and 
3.9 r 0.86 to 83.3 d 21 .lcmfsec and 3.9 r 0.87, N.S. and N.S., respectively) in spite of an 
elevation of the plasma homocystelne level (from 11.7 f 6.4nmollml to 30.6 * 8.64 nmoll 
ml, p<O.OOOl). Moreover, there was a significant negative correlation between plaStTX3 
homocysteine level and CFVR (r=-0.542. p=O.O092). Conclusion: Elevation I” homocys- 
teine concentration induced an acute impairment of coronary vessel resistance, and this 
was completely reverted by vitamin C. Oxidative stress was suggested to play a major 
role I” the deleterious effects of homocysteine on the endothelium of coronary vessels. 
1131-145 Differential Antiplatelet Effects of Angiotensin 
Converting Enzyme Inhibitors: Ex Vivo and In Vitro 
Studies Using Whole Blood Aggregometry 
Dirk Skowasch, Melanie Schneider, Stefanie Schrempf, S&fan Kramer, Mar10 Maylaho. 
Gerhard Baunedel, University of Bonn, Bonn, Germany 
Background: Increasing evidence suggests that angiotensln converting enzyme (ACE) 
inhibitors have antithrombotlc effects. Therefore, we sought to evaluate the coagulative 
ex viva activity of cardiovascular (CV) patients grouped for treatment with either capto- 
pril. ramipril, enalapril, aspirin (ASA) and ASAlclopidogrel or none of these medications 
and. I” addition. the in vitro effects of these ACE Inhibitors on platelet aggregation Of 
healthy study participants. Methods: Blood samples from 303 CV patients and from 10 
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healthy study partlclpants were analyzed by whole-blood aggregometry. Platelet aggre- 
gation was determined by the increase in impedance across paired electrodes in 
response to the aggregatory agents collagen and ADP, respectively. For CV patients, 
these data were regarded for medication. Blood samples from healthy study participants 
were studied after addition of ACE inhibitors in different dosage titrations. Results: As 
the central flnding, platelet aggregation was attenuated ex viva by captopril and ramipril 
as well as by ASA and clopidogrel. While decrease in collagen-induced platelet aggrega- 
tion was significant with captopril (24%: P=O.O2) and ramipril (29%; P=O.O3), an adverse 
increase was seen with enalapril (11%; PcO.05). Following collagen induction, platelet 
aggregation decreased by 23% (PcO.01) with ASA and with ASAiclopidogrel by 35% 
(P=O.O4). After ADP induction, inhibition with ASA!clopidogrel was 85% (PcO.Ol), with 
ASA 19% (P=O.O3) and with captoprll there was a trend of inhibition (27%; P=O.l4); no 
significant antithrombotic effect was seen with ramiprrl or enalapril. In vitro, there was no 
significant change of platelet aggregation after addition of specific ACE Inhibitors. Con- 
clusions: Our findlngs provide direct evidence for ACE inhibitors to decrease platelet 
aggregation ex viva A differential anti-aggregatory profile of ACE inhibitors may explain 
different effects on CV events as observed in large clinical trials. Failure of effects in vitro 
suggests that the antithrombotic effect is not due to direct interaction between ACE inhib- 
itors and thrombocytes. 
POSTER SESSION 
1132 Molecular Cardiology 
Monday, March 31, 2003, 3:00 p.m.-500 p.m. 
McCormick Place, Hall A 
Presentation Hour: 4:00 p.m.-500 p.m. 
1132-120 Fish Oil Attenuates Ox-Low-Density Lipoprotein 
Induced Expression of Adhesion Molecules in Human 
Coronary Artery Endothelial Cells 
Honaiianq Chen, Dayuan Li. Tom Saldeen, Jawahar L. Mehta, University of Arkansas for 
Medical Sciences, Llttle Rock, AR. Central Arkansas Veterans Healthcare System, Little 
Rock, AR 
Background: A number of studies have suggested antt-atherosclerotic effects of fish/ 
fish oil. Uptake of oxidized low-density lipoprotein (ox-LDL) by endothelial cells is an 
early step in atherogenesis. Ox-LDL upregulates expression of adhesion molecules. 
such as P-selectin and intracellular adhesion molecule-l (ICAM-1). We hypothesized 
that fish oil components may reduce ox-LDL-mediated expression of adhesion mole- 
cules. 
Materials & Methods: Cultured human coronary artery endothelial cells (fourth ganera- 
tion) were incubated with ox-LDL (40&ml) for 24 hrs. Parallel groups of cells were pre- 
treated with docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) (IO and 50 
PM), the tw major components of fish oil, for overnight before incubation with ox-LDL. 
Another group of cells was treated with the protein kinase B (PKB) inhibitor wortmannin 
(100 nM) along with DHA (50 pM). 
Results: Ox-LDL markedly increased the expression of P-selectin and ICAM-I (both pro- 
tern and mRNA) in HCAECs, enhanced the adherence of monocytes to the cultured 
endothelail cells, and inhlbited the activity of PKB. Both EPA and DHA decreased ox- 
LDL-induced upregulation of P-se&tin and ICAM-I expression and adherence of mono- 
cytes, and increased the activity of PKB (all PqO.02 vs. ox-LDL alone, n=6). The effects 
of 50 pfv’ concentration were rnwe pronounced than the effects of IO @l (P<O.O5). 
Import&tly, the PKB inhibitor wortmann~n attenuated the effects of DHA (PcO.05). 
Conclusions: The present study shows that both EPA and DHA attenuate the ox-LDL- 
induced expression of adhesion molecules and the adherence of monocytes to the 
endothelial cells These effect of EPA and DHA are mediated by modulation of PKB 
activity. These effects of EPA’DHA may underlie the anti-atherosclerotic effects of fish/ 
fish oils. 
1132-121 Angiotensin Receptor Type 1 (AT,) Independent Growth 
Effects of Intracellular Angiotensin II (Ang II) in Cardiac 
Myocytes 
Ralesh Kumar, Sandhya Sanghi, Kenneth M. Baker, David E. Dostal, The Texas A & M 
University System Health Science Center, Temple, TX 
Background: Cardiac remodeling and growth can be elicited through autocrine and 
paracrine actions of Ang II, vra binding to the AT, plasma membrane receptor. An intrac- 
rim? role for Ang II has been postulated; however, no direct growth related evidence sup- 
ports this postulate. We present evidence of growth promoting effects of intracellular Ang 
II I” rat neonatal cardiac myocytes. Others and we have previously demonstrated AT, 
lkke intracellular Ang II bindlng sites on hepatocyte nuclear envelopes. 
Methods: Neonatal rat ventricular myocytes were infected with the Tet-off adenovirus 
coding for Ang II peptide (Ad_Ang II). The effect on growth was studied by sH-Leucine 
incorporation after 72 h of infection in the presence and absence of the cell permeable 
and impermeable Ang II receptor antagonists, losartan and candesartan, respectively. 
Intracellular and extracellular Ang II levels were measured by a competitive ELISA 
assay. 
Results: In myocytes infected with Ad_Ang II (72 h), the levels of intracellular Ang II 
were increased by 72.4 % (99 + 6 vs 58 * 15 PM) compared to control virus (Ad-Cow) 
An increase of 132 % (378 r 70 vs 162 * 39 PM) in extracellular Ang II levels was also 
observed, possibly due to a positlve-feedback loop. In Ad_Ang II treated myocytes, there 
was a 63.7 f 39.6 % increase in 3H-Leucine incorporation, which was not blocked by 
losartan and candesartan, indicating that this effect was mediated through mechanisms 
independent of an AT, like plasma membrane or nuclear receptor. Conditidned medium 
obtained from Ang II expressing cells stimulated growth in naive cells by 11.1 + 3.5 %. 
which was completely blocked by losartan and candesartan. 
Conclusion: Intracellular Ang II promotes cardiac myocyte growth through mechanisms 
independent of plasma membrane AT, receptor activation and secreted growth factors. 
This observation may represent a second level of control for Ang II mediated growth and 
provides a potentially important target for therapeutic inten ention. 
1132-122 Genetic Determinants of Left Ventricular Mass: The 
Role of Beta-l Adrenoceptor Variation in Normal, 
Athletic, and Disease Populations 
TOW Stanton, John R. Payne, Hugh E. Montgomery, Graham Watt, Anna F. Dominlczak. 
Alan G. Jardine, John M. Connell, University of Glasgow, Glasgow, United Kingdom, 
Unwersity College London, London, United Kingdom 
Background: Left ventricular (LV) mass is an extremely strong predrctor of cardiovascu- 
lar morbidity and mortality in the general population. The beta-l adrenoceptor (Bl AR) is 
a key cell surface signalling protein expressed in the heart. As beta-blocker therapy is 
cardloprotective and myocyie growth is stimulated by receptor agonists. it is possible that 
variation in the receptor gene may affect LV mass.The gene of the Bl AR has two known 
functlonal polymorphisms; one of these confers an amino acid change at position 389 
from glycine (G) to arginine (C). The arginlne-form of the receptor (C) has been demon- 
strated to have far greater actlvrty when bound by agonist and also increased GTP bind- 
ing. Methods & Results: We therefore examined the relationship between this variation 
in the BlAR gene and the effect on LV mass in 3 different populations.The first com- 
prised 2280 healthy individuals with ECG-derived LV mass. No significant difference was 
found between LV mass and BIAR genotype. The second population comprised 207 
healthy males who underwent a IO week cardiovascular training programme. LV mass 
was determined by MRI at the start and end of the training period. No difference was 
found for the increase in LV mass when analysed for BIAR genotype. The third popula- 
bon comprised 249 patients with renal disease with echocardiographically determined LV 
mass. There was a highly significant difference in LV mass between the GG group when 
compared to the other 2 groups, CG:GG pqO.05 and CC:GG pcO.01. There were no sig- 
nificant difference in blood pressure measurments, ejection fraction or age between gen- 
otypes.Omining those on renal replacement therapy, beta-blockers or ACE inhibitors did 
not diminish the strength of the association. 
Conclusion: GenetIc variation at the Bl AR locus is of greater importance in defining LV 
mass in pathologkxl circumstances. 
1132-123 Effects of Vascular Endothelial Growth Factor on 
Proliferation and Differentiation of Embryonic Stem 
Cells 
Yu Chen Yinke Yang, Qingen Ke, Jamal S. Rana, James P. Morgan, Yang-Fu Xrao, -3 
Harvard Medical School, Boston, MA 
Our previous study showed that compared to transplantation of embryonic stern cells 
(ESCs) alone in infarcted hearts, improvement of cardiac function was significantly 
greater in post-infarcted mice transplanted with ESCs overexpressing vascular endothe- 
lial growth factor (VEGF). Accumulated evidence demonstrates that VEGF affects 
embryonic development and stimulates vascular growth. In the present study, we investi- 
gated the effects of VEGF, in vitro, on ESC proliferation and differentiation in the pres- 
ence or absence of leukemia inhibitory factor (LIF). ESC proliferation was measured by 
the MTr method (Cell proliferation kit I, sigma). Compared to the control group, 20 ng/ml 
VEGF did not affect proliferation of ESCs cultured in the presence of LIF (1000 units/ml) 
at 6 and 11 days. However, in the absence of LIF, 20 ngiml VEGF significantly enhanced 
ESC proliferation. The numbers of cells were significantly increased by 45 -t 5% (n = 7) 
and by 79 * 7% (n = 7) at 6 and 11 days in culture, respectively. Similar results were 
observed in the expenments of ESCs transfected with VEGF cDNA (phVEGF165). In 
addition, the hanging drops method was used to evaluate differentiation of ESCs cultured 
in the absence of LIF. The portion of ESCs that differentiated to cardiac a-myow heavy 
chain @-MHC) positive cells was sorted by flow cytometry. Compared to VEGF- 
untreated ESCs. 20 @ml VEGF increased the number of a-MHC positive cells by 84 f 
8% (n = 3) at 11 days in culture. In ESCs transfected with VEGF cDNA. the number of a- 
MHC posltwe cells was increased by 52 * 7% (n = 3) at 11 days in culture Moreover, 
WeStern blot analysis further confirmed that in the absence of LIF, the amwnt ofa-MHC 
protein was significantly increased in ESCs treated with 20 ngiml VEGF or in ESCs 
transfected with VEGF-cDNA. Our data demonstrate that VEGF did not affect orollfera- 
tlon of ESCs cultured in the presence of LIF, but stimulated proliferation and dlfferentia- 
tion of ESCs cultured in the absence of LIF. The information of the VEGF-Induced 
significant increase in differentiation of ESCs to cardiac a-MHC positive cells is probably 
important for future cell therapy to regenerate injured myocardium. 
1132-124 Location of Mutation in the KCNQI Gene Does Not 
Influence Outcome of Long QT Syndrome Patients 
Woiciech Zareba, Arthur J. Moss, Gloria Sheu, Elizabeth S. Kaufman, Jennifer L 
Robinson, Mark L. Andrew, Elizabeth Carroll, for International LQTS Registry 
University of Rochester, Rochester, NY 
Background. Recent data showed that long QT syncrome (LQTS) patrents with mu:ations 
in the pore region of HERG (LQT2) gene have significantly higher risk of cardiac events 
than patients with mutations in non-pore region. The aim of this study was to determine 
whether there IS an association between location of mutations in the KCNQI gene and 
cardiac events in LQTI patients. 
Methods. Study population consisted of 216 LQTI patients with KCNQI gene mutation. 
Demographic, clinical. and follow-up informabon was compared among patients with dif- 
ferent location of KCNQI mutations defined as: prs-pore region including N-terminus (I- 
